ENZOLYTICS, INC.

Other languages Enzolytics, Inc.

Equities

ENZC

US2941121079

Market Closed - OTC Markets Other stock markets 03:59:14 2024-05-08 pm EDT			5-day change	1st Jan Change
0.00396 ^USD	-15.74%		-24.53%	-77.14%

May. 02	Enzolytics, Inc. Announces Formation of Marketing Company in Partnership with Third Coast Fulfillment LLC	CI
Mar. 25	Enzolytics, Inc. Announces Board Changes	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Enzolytics, Inc. Announces Formation of Marketing Company in Partnership with Third Coast Fulfillment LLC	May. 02
Enzolytics, Inc. Announces Board Changes	Mar. 25
Enzolytics, Inc Appoints Steven Sharabura as Chief Executive Officer	Mar. 25
Enzolytics Offers Update on Virogentics, Inc ITV-1 African Project	23-06-26
Enzolytics, Inc. Provides Update on Clinical Trials	23-04-21
Enzolytics Announces Preliminary Results of GLP Toxicology Study for its anti-HIV Therapeutic ITV-1 and Production of ITV-1 for Initiation of Registration in Africa	23-02-08
Enzolytics to Develop Feline Monoclonal Antibodies	23-01-03
Enzolytics, Inc. Announces U.S. Distribution of IPF Immune(TM) and Progress in each of its Therapeutic Platforms	22-12-13
Enzolytics, Inc. Announces Expansion of Production of Its Monoclonal Antibody Therapeutics and Marketing of IPF Immune	22-11-16
Enzolytics, Inc. Appoints Dr. Kirsten Bischof to Its Advisory Board	22-10-24
Enzolytics Inc. Reports Successful Completion of an MTD Tolerability Study of Its ITV-1 anti-HIV Therapeutic Leading to the Start of a 28-day GLP Toxicology Study	22-10-05
Enzolytics Inc. Announces Collaboration with Abveris to Discover Monoclonal Antibodies	22-09-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW